Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non-small cell lung cancer.

Guo X, Li H, Fei F, Liu B, Li X, Yang H, Chen Z, Xing J.

Mol Carcinog. 2015 Jun;54 Suppl 1:E52-60. doi: 10.1002/mc.22167. Epub 2014 Apr 30.

PMID:
24782339
2.

Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.

Yang Y, Fei F, Song Y, Li X, Zhang Z, Fei Z, Su H, Wan S.

Cancer Sci. 2014 Jan;105(1):89-96. doi: 10.1111/cas.12318. Epub 2013 Dec 4.

3.

Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.

Guo X, Li D, Wu Y, Chen Y, Zhou X, Wang X, Huang X, Li X, Yang H, Xing J.

Lung Cancer. 2015 Feb;87(2):162-8. doi: 10.1016/j.lungcan.2014.12.005. Epub 2014 Dec 18.

PMID:
25576295
4.

Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer.

Guo X, Chen C, Liu B, Wu Y, Chen Y, Zhou X, Huang X, Li X, Yang H, Chen Z, Xing J.

Tumour Biol. 2015 May;36(5):3931-9. doi: 10.1007/s13277-014-3036-0. Epub 2015 Jan 13.

PMID:
25578492
5.

A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.

Xu J, Yin Z, Shen H, Gao W, Qian Y, Pei D, Liu L, Shu Y.

PLoS One. 2013 Nov 6;8(11):e79135. doi: 10.1371/journal.pone.0079135. eCollection 2013.

6.

Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery.

Liu B, Liu Q, Song Y, Li X, Wang Y, Wan S, Zhang Z, Su H.

Med Oncol. 2014 Apr;31(4):877. doi: 10.1007/s12032-014-0877-8. Epub 2014 Feb 25.

7.

Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.

Zhang K, Tang S, Cao S, Hu L, Pan Y, Ma H, Guo X, Wu S, Shen H, Hu Z.

Cancer Epidemiol. 2014 Aug;38(4):414-8. doi: 10.1016/j.canep.2014.03.013. Epub 2014 May 3.

PMID:
24797335
8.

Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.

Ma H, Chen J, Pan S, Dai J, Jin G, Hu Z, Shen H, Shu Y.

Lung Cancer. 2011 Jul;73(1):32-7. doi: 10.1016/j.lungcan.2010.11.001. Epub 2010 Dec 9.

PMID:
21145615
9.

Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery.

Jin X, Zhang KJ, Guo X, Myers R, Ye Z, Zhang ZP, Li XF, Yang HS, Xing JL.

Asian Pac J Cancer Prev. 2014;15(17):7097-103.

10.

Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients.

Coscio A, Chang DW, Roth JA, Ye Y, Gu J, Yang P, Wu X.

Carcinogenesis. 2014 Jun;35(6):1284-91. doi: 10.1093/carcin/bgu034. Epub 2014 Feb 11.

11.

Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.

Ma H, Shu Y, Pan S, Chen J, Dai J, Jin G, Hu Z, Shen H.

Lung Cancer. 2011 Nov;74(2):164-9. doi: 10.1016/j.lungcan.2011.03.005. Epub 2011 Apr 22.

PMID:
21514686
12.

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman SM, Hong WK, Spitz MR, Romkes M, Yang P.

J Natl Cancer Inst. 2011 May 18;103(10):817-25. doi: 10.1093/jnci/djr075. Epub 2011 Apr 11.

13.

Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.

Masago K, Fujita S, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Irisa K, Ichikawa M, Mio T, Mishima M.

Cancer Sci. 2009 Oct;100(10):1917-22. doi: 10.1111/j.1349-7006.2009.01253.x. Epub 2009 Jun 23.

14.

Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.

Lee Y, Yoon KA, Joo J, Lee D, Bae K, Han JY, Lee JS.

Carcinogenesis. 2013 Feb;34(2):307-13. doi: 10.1093/carcin/bgs356. Epub 2012 Nov 8.

15.

Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.

Xu JL, Hu LM, Huang MD, Zhao W, Yin YM, Hu ZB, Ma HX, Shen HB, Shu YQ.

Asian Pac J Cancer Prev. 2012;13(3):851-6.

16.

FoxP3 genetic variants and risk of non-small cell lung cancer in the Chinese Han population.

He YQ, Bo Q, Yong W, Qiu ZX, Li YL, Li WM.

Gene. 2013 Dec 1;531(2):422-5. doi: 10.1016/j.gene.2013.08.066. Epub 2013 Sep 10.

PMID:
24035934
17.

CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.

Song B, Liu Y, Liu J, Song X, Wang Z, Wang M, Zhu Y, Han J.

Respiration. 2011;82(5):439-44. doi: 10.1159/000329345. Epub 2011 Aug 11.

PMID:
21832820
18.

Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese.

Dai J, Hu Z, Dong J, Xu L, Pan S, Jiang Y, Jin G, Chen Y, Shen H.

Int J Cancer. 2012 Feb 1;130(3):671-6. doi: 10.1002/ijc.26067. Epub 2011 May 9.

19.

Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.

Kim SH, Lee GW, Lee MJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim IS, Lee S, Oh SY.

Lung Cancer. 2012 Sep;77(3):578-84. doi: 10.1016/j.lungcan.2012.04.016. Epub 2012 May 18.

PMID:
22608006
20.

The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients.

Li Y, Geng J, Wang Y, Lu Q, Du Y, Wang W, Li Z.

J Cancer Res Clin Oncol. 2012 Feb;138(2):311-6. doi: 10.1007/s00432-011-1098-6. Epub 2011 Nov 30.

PMID:
22127368
Items per page

Supplemental Content

Write to the Help Desk